US Activist Hedge Fund Institutional SEC 13D 13G — August 24, 2026

24-08-2026

GAMCO Investors, Inc. et al. filed a Schedule 13D/A with the SEC on August 24, 2026, disclosing aggregate beneficial ownership of 7,332,244 shares (20.98%) of Tredegar Corp. The filing details holdings by multiple Gabelli-affiliated entities, with GAMCO Asset Management Inc. holding the largest stake at 5,793,944 shares (16.58%). Recent transactions include two small sales by GAMCO Asset Management Inc. in August 2026, totaling 6,000 shares at prices between $7.87 and $8.23.

• · GAMCO Asset Management Inc. sold 5,000 shares on August 21, 2026 at $7.8714 per share and 1,000 shares on August 11, 2026 at $8.2307 per share.
• · GAMCO does not have authority to vote 384,500 of its reported shares.
• · The filing is an amendment to a prior Schedule 13D, filed as a long-form 13D despite eligibility for short-form 13G, to ensure compliance with Exchange Act reporting obligations due to regular communications with issuer management.
• · Gabelli Funds LLC has sole dispositive and voting power over its shares subject to a 25% aggregate voting interest cap; its Proxy Voting Committee may exercise full voting power under special circumstances.

24-08-2026

Star Equity Fund, LP filed an amended Schedule 13D disclosing a Cooperation Agreement with GEE Group Inc. (JOB) dated August 21, 2026. Under the agreement, GEE Group will declassify its Board of Directors so that a majority of directors serve one-year terms starting at the 2027 Annual Meeting, and Star Equity withdrew its nomination of Richard K. Coleman, Jr. for the Board and agreed to a standstill. Star Equity Fund beneficially owns 6,285,065 shares (approximately 5.72% of the outstanding common stock) as of August 24, 2026, with an aggregate purchase price of approximately $1,237,245.

• · Star Equity Fund purchased shares in open market between July 2 and July 29, 2026, at prices ranging from $0.21 to $0.22 per share.
• · The Cooperation Agreement includes a voting commitment, standstill, mutual non-disparagement, and other customary provisions.
• · Richard K. Coleman, Jr. ceased to be a Reporting Person and holds 0 shares as of August 24, 2026.
• · The Cooperation Agreement terminates on the earlier of the opening of the advance notice period for the 2027 Annual Meeting or 120 days prior to the one-year anniversary of the 2026 Annual Meeting.

24-08-2026

Andrew M. Cohn and Amy Cohn filed a Schedule 13D/A disclosing their acquisition of 139,343 shares of Global Water Resources, Inc. (GWRS) for $1,233,185.55 on August 20, 2026, funded from personal funds. The Reporting Persons now beneficially own 2,743,500 shares, representing approximately 9.17% of outstanding common stock. Concurrently, the Cohns and other shareholders entered into a Standstill Agreement that caps Andrew M. Cohn's aggregate beneficial ownership at 9.9% of voting power, while board-member shareholders may receive equity compensation up to 49.0% voting power.

• · The Reporting Persons disclaim beneficial ownership of shares except for their pecuniary interest.
• · The Standstill Agreement also covers Levine Investments Limited Partnership, William S. Levine, and Jonathan Levine.
• · Board-member shareholders may receive equity compensation up to 49.0% voting power; excess compensation is replaced with cash.
• · The Reporting Persons' business address is 2801 E. Camelback Rd. Suite 450, Phoenix, Arizona 85016.
• · Andrew M. Cohn's principal occupation is real estate investment; Amy Cohn is a homemaker.

24-08-2026

Jorey Chernett, a private investor and founder of Pointillist Family Office, filed a Schedule 13D with the SEC on August 24, 2026, disclosing beneficial ownership of 1,461,750 shares (approximately 5.5%) of CVRx, Inc. (NASDAQ: CVRx). In a letter to the Board, Chernett urged the company to immediately retain an independent financial advisor and initiate a strategic review with a sale of the company as the priority outcome, arguing that Barostim would be uniquely valuable to a large medical device company. The filing also reveals that Chernett purchased shares at an average price of $2.70 on August 7, 2026, after selling shares at higher prices earlier in July, indicating a recent accumulation at lower prices.

• · Chernett previously reported beneficial ownership on Schedule 13G filed August 14, 2026, which is now superseded by this Schedule 13D.
• · Chernett sold 200 shares at $5.82 on July 7, 2026, and 18,374 shares at $4.72 on July 20, 2026, before purchasing 1,000 shares at $4.951 on August 6, 2026, and 405,000 shares at $2.70 on August 7, 2026.
• · Chernett has sole voting and dispositive power over all 1,461,750 shares.
• · The letter to the Board argues that a sale can be accretive to a strategic acquirer within twelve months and that CVRx's cash position and momentum make a sale now more favorable than waiting.
• · Chernett states he may engage in further communications with management, board, and stockholders, and may recommend changes to capitalization, board composition, or business combinations.

24-08-2026

This Schedule 13D/A filing discloses that Mark E. Jones and related parties (the Reporting Persons) collectively beneficially own 12,462,089 shares of Goosehead Insurance Class A Common Stock, representing 34.2% of the outstanding shares. The filing updates the group's holdings and reaffirms existing voting agreements and exchange rights. No material changes in ownership or control were reported.

• · The Reporting Persons have entered into Voting Agreements that grant Mark E. Jones an irrevocable proxy to vote all shares of Class A and Class B Common Stock held by the group.
• · Each share of Class B Common Stock (together with an LLC Unit of Goosehead Financial) is exchangeable for one share of Class A Common Stock on a one-for-one basis.
• · The Issuer has a tax receivable agreement with pre-IPO members of Goosehead Financial, providing for payment of 85% of tax benefits realized from increases in tax basis resulting from exchanges of membership units.
• · Serena Jones is a citizen of Canada; all other natural person Reporting Persons are U.S. citizens.
• · None of the Reporting Persons has been convicted in a criminal proceeding or been subject to securities-related civil proceedings in the last five years.

24-08-2026

Fresenius SE & Co. KGaA filed an amended beneficial ownership report on Schedule 13D/A, disclosing that on August 20, 2026 it entered into a block trade agreement with J.P. Morgan SE to sell 7,800,000 ordinary shares of Fresenius Medical Care AG (about 2.97% of total share capital) at €39.56 (~$46.16) per share. Following the sale, Fresenius KGaA retains ownership of 67,181,358 shares, representing 25.6% of outstanding voting shares, down from its prior approximate 28.6% stake, reflecting a partial monetization as part of its portfolio optimization strategy. The filing also details ongoing open-market sales over the past 60 days, totaling approximately 2.4 million shares sold, to maintain ownership percentage in light of the company's share buyback program.

• · The block trade is expected to close on August 25, 2026.
• · Fresenius KGaA agreed to a 45-day lock-up period from August 21, 2026, restricting further sales without the Purchaser's consent.
• · The share buyback program of Fresenius Medical Care AG is ongoing and reduced total outstanding shares to 262,699,356 as of August 21, 2026.
• · Past 60-day open-market sales ranged in volume from 3,277 to 112,399 shares per day, with volume-weighted average prices from €39.49 to €45.08.
• · Fresenius KGaA's supervisory board includes employee representatives under German co-determination law, while the Management SE board does not.

24-08-2026

Tencent Holdings Ltd filed a Schedule 13D/A with the SEC on August 24, 2026, disclosing that it ceased to be a beneficial owner of more than 5% of Amer Sports, Inc. ordinary shares as of August 20, 2026. Tencent now holds 15,794,146 ordinary shares (2.7% of total outstanding), down from a prior stake above 5%. The filing indicates a significant reduction in Tencent's ownership position in Amer Sports.

• · Tencent's holdings consist of 13,871,069 shares held by Huang River Investment Limited and 1,923,077 shares held by Bright Adventure Holding Limited.
• · No transactions in ordinary shares were effected by Tencent or related persons during the past 60 days.
• · The filing is an amendment (Schedule 13D/A) to a prior Schedule 13D.

24-08-2026

Wang Junyuan filed a Schedule 13G with the SEC on August 24, 2026, disclosing beneficial ownership of 2,670,000 Class A ordinary shares of Agencia Comercial Spirits Ltd. (AGCC), representing approximately 6.24% of the 42,786,500 Class A ordinary shares outstanding as of July 31, 2026. The filing indicates the shares are held for investment purposes and not with the intent to change or influence control of the issuer. This is a routine beneficial ownership disclosure and does not reflect any change in company operations or financial performance.

• · The filing is made under Rule 13d-1(c) of the Securities Exchange Act of 1934.
• · The shares are held directly by Wang Junyuan, with no shared voting or dispositive power.
• · The issuer is incorporated in Taiwan (R.O.C.) and its principal executive offices are located at No. 23-1, Shenzun Rd., Shengang Dist., Taichung City 429014, Taiwan.
• · The company changed its name from Agencia Comercial Co., Ltd to Agencia Comercial Spirits Ltd. on March 11, 2025.

24-08-2026

CK Amarillo LP and its affiliates (Knighthead Capital Management, Certares Opportunities) disclosed beneficial ownership of 181,455,469 shares of Hertz Global Holdings common stock, representing 50.9% of outstanding shares as of July 30, 2026. In connection with litigation settlement, the company entered into an amended voting agreement capping CK Amarillo's voting power at 45% and requiring a sale-of-control provision that could benefit other shareholders if CK Amarillo sells a large stake above market price. The filing reflects a major shareholder's continued dominant position but with governance constraints.

• · The amended voting agreement was entered on August 20, 2026 in connection with settlement of the Cascia v. Farmer, et al. litigation.
• · The voting agreement caps voting power at 45% and requires CK Amarillo to vote excess shares in proportion to other stockholders.
• · A sale-of-control provision requires CK Amarillo to compensate other shareholders if it sells 50% or more of outstanding shares above market price.
• · The voting agreement terminates when CK Amarillo's beneficial ownership falls below 45% and the company has either expended all funds authorized under the Repurchase Programs or terminated them.

24-08-2026

Solana Rocket Holdings Ltd and its controlling shareholder CHUNG Wai Shing filed an amended Schedule 13G disclosing a 9.99% beneficial ownership stake in Solana Co as of August 12, 2026, capped by a beneficial ownership blocker. The stake comprises 3,004,154 shares of common stock, pre-funded warrants for up to 215,966 shares, and cash stapled warrants for up to 14,823,426 shares, though the blocker limits effective ownership to 6,376,746 shares based on 60,458,703 shares outstanding.

• · The beneficial ownership is capped at 9.99% by a Beneficial Ownership Blocker that prohibits exercise of warrants beyond that threshold.
• · Solana Rocket Holdings Ltd is a British Virgin Islands company; CHUNG Wai Shing resides in Hong Kong, China.
• · The 13G/A references the company's Form 10-Q filed August 14, 2026, confirming 60,458,703 shares outstanding.

24-08-2026

Alta Partners LLC filed a Schedule 13G with the SEC on August 24, 2026, disclosing beneficial ownership of 53,060 Class A Ordinary Shares of NFT Ltd, representing 9.9% of the outstanding shares. The filing indicates the shares were acquired in the ordinary course of business and not with the intent to change or influence control of the issuer.

• · Alta Partners LLC is a New York limited liability company with its business address at 29 Valentines Lane, Old Brookville, NY.
• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · The beneficial ownership includes 32,654 shares held directly and 20,406 shares issuable upon exercise of warrants, subject to a 9.99% beneficial ownership limitation.
• · An additional 145,986 shares issuable upon exercise of warrants are excluded from the reported beneficial ownership due to the same limitation.

24-08-2026

L1 Capital Global Opportunities Master Fund, Ltd. filed a Schedule 13G with the SEC on August 24, 2026, disclosing beneficial ownership of 2,028,885 shares of Dare Bioscience, Inc. common stock (including shares underlying Series A Warrants), representing 9.99% of the outstanding shares. The filing indicates the fund holds additional warrants (Series A and Series B) that are subject to the same 9.99% ownership limitation and are not counted in the reported amount.

• · The 2,028,885 shares consist of 1,094,890 shares of Common Stock and 933,995 Series A Warrants.
• · An additional 160,895 Series A Warrants and 1,094,890 Series B Warrants are held but not included in the beneficial ownership calculation due to the 9.99% limitation.
• · The filing is made under Rule 13d-1(c), indicating the fund acquired the securities in the ordinary course of business and not with the purpose of changing or influencing control.
• · David Feldman and Joel Arber are directors of the fund and may be deemed to beneficially own the securities, but they disclaim beneficial ownership for all other purposes.

24-08-2026

Scilex Holding Company filed an amended Schedule 13D disclosing it has beneficial ownership of 163,766,229 shares of Datavault AI Inc. common stock, representing 17.2% of outstanding shares. On August 8, 2026, Scilex established an uncommitted $20M revolving credit facility for Vivasor Inc., and on August 20, 2026, it transferred 50 million Datavault shares to Vivasor as an initial drawdown at $0.3151 per share. The filing reflects a significant ownership stake but no change in Scilex's overall share count from prior filings, and no other transactions in the past 60 days.

• · The Vivasor Note has a 120-month maturity from August 8, 2026, with interest at 5% per annum on a 360-day basis.
• · Drawdowns under the Vivasor Note may be funded in cash, freely tradable Scilex securities, or Datavault common shares held by Scilex.
• · The credit facility is uncommitted — Scilex has no obligation to fund any drawdown.
• · No transactions in Datavault common stock by Scilex during the past 60 days prior to filing, other than the August 20 transfer.
• · The filing is Amendment No. 5 to the original Schedule 13D filed October 2, 2025.

24-08-2026

Robert A. Ortenzio, a major shareholder of Concentra Group Holdings Parent, Inc., filed an amended Schedule 13D disclosing a stock repurchase agreement with the company. On August 21, 2026, the company agreed to repurchase 1,000,000 shares from Ortenzio and related trusts at $34.65 per share, for an aggregate purchase price of $34,650,000. Following the transaction, Ortenzio's beneficial ownership decreased to approximately 5.3% of outstanding shares, down from a prior level not specified in this filing.

• · The repurchase was a privately negotiated transaction, not an open-market buyback.
• · Ortenzio's sole voting and dispositive power covers 4,763,794 shares; shared power covers 1,984,428 shares.
• · The repurchase involved shares held by Ortenzio and four related trusts, with specific allocations detailed in Schedule I (not provided in the filing text).
• · The filing includes representations that the transaction complies with the company's insider trading policy and does not modify any existing Rule 10b5-1 trading plans.

24-08-2026

LNA Holding SRL, an affiliate of Lhoist Group, filed a Schedule 13D disclosing a 15.4% stake in Martin Marietta Materials Inc. The stake was acquired on August 21, 2026, as part of the consideration for Martin Marietta's acquisition of Lhoist North America, Inc. for $7 billion in cash and 10,953,543 newly issued shares. The filing includes a shareholders' agreement with a lock-up (50% released at 12 months, remainder at 24 months), board representation rights, and a standstill provision capping further share purchases at 12,783,660 shares.

• · Lock-up: 50% of Consideration Shares released at 12 months, remaining 50% at 24 months from closing.
• · Board representation: LNH can designate one director and one non-voting observer while owning at least 7,102,033 shares; reduced to one director if ownership falls below that but remains at or above 5,326,525 shares; all rights terminate below 5,326,525 shares.
• · Standstill: LNH and affiliates cannot acquire shares exceeding 12,783,660 shares until 15 months after LNH loses all board/observer rights or holds fewer than 5,326,525 shares.
• · Registration Rights Agreement provides shelf, demand, and piggyback registration rights for the Consideration Shares.
• · Reporting Persons may engage in discussions regarding extraordinary corporate transactions including mergers, asset sales, or changes in capitalization.

24-08-2026

Blackstone Private Real Estate Credit & Income Fund filed Amendment No. 11 to Schedule 13D, reporting beneficial ownership of 27,361,476.82 common shares, representing 70.1% of the 39,049,837.734 shares outstanding as of August 21, 2026. The amendment disclosed additional subscriptions by affiliated funds totaling 277,403.859 shares for an aggregate purchase price of $7,251,859.68, funded with working capital; however, the filing does not provide a prior-period ownership percentage for calculating a period-over-period change.

• · Amendment No. 11 amends the Schedule 13D originally filed on June 27, 2025, with the immediately preceding Amendment No. 10 filed on July 24, 2026.
• · BREC-S was deemed to acquire its June 1, 2026 subscription on June 23, 2026, when the Common Shares' net asset value was determined.
• · BMACX and BREC-S were deemed to acquire their August 1, 2026 subscriptions on August 21, 2026, when the Common Shares' net asset value was determined.
• · All three disclosed investments were funded from working capital.
• · The filing identifies 20 Reporting Persons that may be deemed to beneficially own shares directly or indirectly controlled by them.
• · The fund's business address is 345 Park Avenue, New York, New York 10154.

24-08-2026

Starboard Value LP filed Amendment No. 3 to its Schedule 13D for BILL Holdings, Inc., disclosing aggregate beneficial ownership of 8,639,900 shares (10.1% of outstanding shares) as of August 24, 2026. The filing was triggered solely by a reduction in BILL's total shares outstanding to 85,276,782, which increased Starboard's percentage ownership. No new transactions were entered into during the past sixty days, and Peter A. Feld, a Starboard partner, serves on BILL's board with 7,831 RSUs awarded.

• · Starboard's ownership percentage increased to 10.1% solely due to a reduction in BILL's outstanding shares from a prior higher count to 85,276,782.
• · No transactions in BILL shares were conducted by Starboard during the past 60 days.
• · Peter A. Feld was awarded 7,831 RSUs vesting in three equal annual installments starting October 17, 2026, with 2,610 RSUs vesting within 60 days of the filing date.

24-08-2026

Integrated Core Strategies (US) LLC, an affiliate of Millennium Management, disclosed a 5.4% beneficial ownership stake in Collegium Pharmaceutical, Inc. as of August 17, 2026, holding 1,769,122 shares. Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported a 5.6% stake (1,820,330 shares), with the filing made under Rule 13d-1(c) as a passive investor without intent to influence control.

• · Filing made under Rule 13d-1(c) as a passive investor, certifying no intent to change or influence control of Collegium Pharmaceutical.
• · Integrated Core Strategies (US) LLC is a Delaware LLC with business address c/o Millennium Management LLC, 399 Park Avenue, New York, NY 10022.
• · Joint Filing Agreement dated August 21, 2026, among the reporting entities and Israel A. Englander.
• · The securities reported by Millennium Management LLC, Millennium Group Management LLC, and Mr. Englander are held by entities subject to their voting control and investment discretion.

24-08-2026

Alafi Capital Company LLC and Christopher D. Alafi filed an amended Schedule 13D with the SEC on August 24, 2026, reporting that on August 19, 2026, they received 3,529,192 Series A Warrants and 3,529,192 Series B Warrants from CalciMedica, Inc. following stockholder approval. The reporting persons collectively hold 7,220,101 shares and warrants (19.9% of the issuer's common stock on a diluted basis), but the newly received warrants are not currently exercisable due to a 19.99% beneficial ownership limitation. No other transactions were effected in the past 60 days.

• · The filing is an amendment to Schedule 13D triggered solely by the issuance of warrants on August 19, 2026.
• · The reporting persons disclaim beneficial ownership of shares beyond their pecuniary interest.
• · No transactions in the issuer's securities were effected by the reporting persons within the past 60 days.

24-08-2026

Suzano Holding S.A. and related parties filed a Schedule 13D with the SEC on August 24, 2026, disclosing a new shareholders' agreement (the Fanny Parties Shareholders' Agreement) effective August 20, 2026, which may cause the reporting persons to be deemed a group under Section 13(d)(3) of the Securities Exchange Act. The agreement governs a 20-year corporate reorganization where Fanny Parties will gradually exchange their shares in Suzano Holding for common shares of Suzano S.A., with the Fanny Parties waiving any rights to elect board members or influence corporate control. The filing replaces a prior Schedule 13G and confirms that the Controlling Shareholder Group's beneficial ownership has not changed materially since February 2024.

• · The Schedule 13D replaces a prior Schedule 13G filed by the Controlling Shareholder Group (last amended February 14, 2024).
• · The Fanny Parties Shareholders' Agreement became effective on August 20, 2026.
• · The SH Corporate Reorganization may be accelerated if the Controlling Shareholder Group receives a firm, bona fide, irrevocable third-party proposal for transfer of control of SH or Suzano S.A.
• · Fanny Parties have irrevocably waived any right to elect members of the Issuer's Board of Directors or Fiscal Council.
• · The Fanny Parties do not meet the requirements to be deemed controlling shareholders under Article 116 of the Brazilian Corporations Law.
• · On June 18, 2026, an Extraordinary General Meeting of Suzano Holding approved a disproportionate reduction in share capital by cancelling 8,772,223 common shares held by certain shareholders.
• · The Shares held by David Feffer were acquired through inheritance, gift, equity awards (as director compensation), and open market purchases.
• · The Shares held by the Fanny Parties were acquired mainly through inheritance, gift, and the SH Corporate Reorganization.

24-08-2026

In Amendment No. 41 to Schedule 13D, Gulf Hungary Holding and its wholly-owned subsidiary QH Hungary Holdings reported that on August 20, 2026, 5,017 shares of Quaker Chemical common stock were released from escrow to satisfy indemnification obligations related to the acquisition of Global Houghton Ltd., while 3,905 shares were returned to Gulf Hungary. After the transactions, QH Hungary directly owns 3,635,112 shares (21.1% of outstanding) and Gulf Hungary directly owns 3,905 shares, with all QH Hungary shares remaining subject to the Shareholder Agreement. The filing reflects a reduction in the total beneficial ownership from 3,644,034 shares to 3,639,017 shares, but the percentage ownership remained unchanged at 21.1%.

• · The filing is Amendment No. 41 to the original Schedule 13D filed on August 9, 2019.
• · Of the 3,635,112 shares owned by QH Hungary, 2,100,000 are pledged to Citigroup Global Markets Inc. under a margin loan, 1,137,630 are pledged to Citibank under prepaid variable share forward transactions, and 397,482 are pledged to Royal Bank of Canada under similar transactions.
• · The escrow release on August 20, 2026 reduced the total shares held in escrow from 8,922 to 3,905 shares returned to Gulf Hungary.

24-08-2026

Brian Valania, CEO, CFO, and director of Mitesco, Inc., filed a Schedule 13D disclosing beneficial ownership of 3,421,078 shares of common stock, representing 7.1% of outstanding shares as of August 17, 2026. The shares were acquired as compensation for services, including 3,000,000 restricted shares on August 3, 2026 at $0.035 per share (aggregate value $105,000) and 205,473 shares on July 10, 2026 at $0.08 per share. Valania also holds 7,200 shares of Series X Preferred Stock, each carrying 400 votes, but these are not included in the common stock percentage.

• · Valania acquired 215,605 shares on July 29, 2024, 205,473 shares on July 10, 2026 at $0.08/share, and 3,000,000 restricted shares on August 3, 2026 at $0.035/share.
• · Valania holds 7,200 shares of Series X Preferred Stock (2,400 acquired May 1, 2026; 4,800 acquired July 10, 2026), each carrying 400 votes, but these are not included in the common stock percentage.
• · Valania has sole voting and dispositive power over all 3,421,078 common shares and no shared power.
• · The shares were acquired as compensation for services; no personal or borrowed funds were used.
• · Valania has no specific plans for any of the matters described in Items 4(a) through 4(j) of Schedule 13D.

24-08-2026

Integrated Core Strategies (US) LLC, an affiliate of Millennium Management, filed a Schedule 13G disclosing beneficial ownership of 11,579,445 shares of Tenaya Therapeutics, Inc. (TNYA), representing 5.2% of the outstanding common stock as of August 17, 2026. The filing is a passive investment disclosure under Rule 13d-1(c) and does not indicate any intent to change or influence control of the company.

• · The filing is a Schedule 13G (passive investment), not a 13D (activist).
• · Israel A. Englander is the ultimate controlling person of the reporting entities.
• · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers.

24-08-2026

Robinson Value Management, Ltd. filed a Schedule 13G with the SEC on August 24, 2026, disclosing beneficial ownership of 2,090,279 shares of Direxion Shares ETF Trust as of June 30, 2026. This position represents an 8.5% stake in the trust, held in discretionary investment advisory accounts for clients. No single client holds more than 5% of the class, and the filing certifies the shares were acquired in the ordinary course of business without intent to influence control.

• · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · Robinson Value Management, Ltd. is a Texas limited partnership and an investment adviser (IA).
• · The filer has sole voting power and sole dispositive power over all 2,090,279 shares.
• · The filing certifies that the securities were not acquired to change or influence control of the issuer.

24-08-2026

Millennium Management LLC and related entities filed a Schedule 13G/A disclosing beneficial ownership of 1,644,000 Class A Ordinary Shares of Catalyst Acquisition Corp., representing 7.7% of the outstanding shares as of August 17, 2026. The filing reflects a passive investment stake, with the filers certifying the securities were not acquired to change or influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed on August 24, 2026, with a date of change of August 17, 2026.
• · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Israel A. Englander.
• · The filers disclaim beneficial ownership of securities held by entities they control, except to the extent of their pecuniary interest.
• · A Joint Filing Agreement dated August 21, 2026, was executed among the reporting persons.

24-08-2026

Kevyn Wynn and Gillian Wynn each reported beneficial ownership of 5,819,401 and 5,819,402 shares of Wynn Resorts, respectively, representing 5.65% of the company's outstanding common stock as of June 30, 2026. The filing is an amendment to Schedule 13G, indicating passive investment intent, and includes shares held through various trusts. The Elaine P. Wynn Family Trust reported zero beneficial ownership.

• · Kevyn Wynn's holdings include 3,719,675 shares via the Wildrose Lane Foundation and 2,099,726 shares via trusts (EPW 2024 Grantor Retained Annuity Trust and EPW 2020 Five Year Trust).
• · Gillian Wynn's holdings include 3,719,676 shares via the Mayten Foundation and 2,099,726 shares via the same trusts.
• · The filing is made under Rule 13d-1(c), confirming passive investment intent.
• · The Elaine P. Wynn Family Trust - 2016 reported zero shares and 0% ownership.

24-08-2026

3i, LP and affiliated entities filed Amendment No. 4 to Schedule 13D, disclosing beneficial ownership of 2,102,780 shares of Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) common stock, representing 9.9% of the 20,913,373 shares outstanding. The filing details multiple conversions of Series B and Series C Preferred Stock into common shares between July and August 2026, as well as recent sales of common stock by 3i, LP at prices ranging from $0.1143 to $0.1763 per share.

• · The filing is an amendment to Schedule 13D originally filed on August 3, 2026, with prior amendments on August 11, 14, and 19, 2026.
• · Beneficial ownership includes shares directly held, shares issuable upon exercise of warrants, and shares issuable upon conversion of a senior secured convertible note, Series B Preferred Stock, and Series C Preferred Stock, all subject to a 9.99% blocker.
• · 3i, LP sold a total of 443,361 shares of common stock in three transactions between August 20 and August 24, 2026, at prices between $0.1143 and $0.1763 per share.
• · On August 20, 2026, 3i, LP acquired 2,020,404 shares of common stock upon conversion of Series C Preferred Stock at a conversion price of $0.39 per share.
• · The company changed its name from Tivic Health Systems, Inc. to Valion Bio, Inc. effective September 10, 2019.

24-08-2026

Jorey Chernett filed Amendment No. 4 to his Schedule 13D with the SEC on August 24, 2026, disclosing beneficial ownership of 10,602,988 shares of Neuronetics, Inc. common stock, representing approximately 13.92% of the 76,197,222 shares outstanding as of August 5, 2026. The amendment was triggered by a change in the issuer's outstanding shares reported in Neuronetics' Form 10-Q filed August 11, 2026, and also reports a recent open-market purchase of 14,000 shares at a weighted average price of $3.16 per share on August 14, 2026. Mr. Chernett's aggregate purchase price for all shares is approximately $20,726,476.

• · The filing is an amendment (No. 4) to an initial Schedule 13D filed March 31, 2026.
• · The ownership percentage is based on 76,197,222 shares outstanding as of August 5, 2026, per Neuronetics' Form 10-Q filed August 11, 2026.
• · Mr. Chernett has sole voting and dispositive power over all 10,602,988 shares.
• · The 14,000 shares purchased on August 14, 2026, were bought in multiple transactions at prices ranging from $3.13 to $3.17 per share (weighted average $3.16).
• · No shares were sold by Mr. Chernett since the prior amendment.

24-08-2026

D. E. Shaw & Co., L.P. and related entities filed Amendment No. 3 to Schedule 13D, disclosing aggregate beneficial ownership of 29,128,194 common shares (6.0%) of Gossamer Bio, Inc. as of August 20, 2026. The filing details a series of sales of common shares between July 27 and August 24, 2026, reducing their stake from a prior level. The transactions were executed at prices ranging from approximately $0.14 to $0.25 per share, reflecting a decline in the stock price during the period.

• · D. E. Shaw entities sold a total of 4,000,000+ shares between July 27 and August 24, 2026, with the largest sale by Valence on July 27 (1,421,600 shares at $0.1841).
• · The weighted average sale prices ranged from $0.1434 to $0.2167 per share, indicating a decline in stock price from the start to the end of the reporting period.
• · The filing references a Transaction Support Agreement dated May 18, 2026 and an Indenture for Senior Secured First Lien Convertible Notes due 2030, indicating ongoing financial arrangements.
• · The filing includes a Joint Filing Agreement dated August 24, 2026, among the reporting persons.

24-08-2026

Sound Group Inc. (SOGP) disclosed in a Schedule 13G filing that Thirumala Srinidhi beneficially owns 342,000 ADSs, representing 68,400,000 Class A Ordinary Shares, or 11.18% of the company's outstanding Class A shares as of April 30, 2026. The ownership is passive in nature, with no intention to change or influence control of the issuer. The filing was made under Rule 13d-1(c), indicating the shareholder is not an activist investor.

• · The ownership percentage is calculated based on 611,614,150 Class A Ordinary Shares outstanding as of February 28, 2026, excluding 841,050 shares held by Kastle Limited.
• · The filing was made under Rule 13d-1(c), indicating the securities are not held for the purpose of changing or influencing control of the issuer.
• · The company was formerly known as LIZHI INC. and changed its name on July 23, 2019.
• · The company is incorporated in Singapore (state of incorporation: E9) and its fiscal year ends on December 31.

24-08-2026

Mzilikazi Godfrey Khumalo filed a Schedule 13D/A disclosing two significant transactions in Namib Minerals ordinary shares: (i) the sale of 4,886,996 shares at an average of ~$3.46/share between August 2025 and February 2026, and (ii) a share loan agreement dated June 29, 2026, with Southern SelliBen Trust under which Khumalo borrowed up to 14 million shares. Following the sale, Khumalo’s beneficial ownership dropped from 7.1% to 7.1% (stated as 4,000,000 shares still held), but the share loan adds substantial off-balance-sheet exposure and potential dilution risk, while the lender holds a security interest in Khumalo’s future earnout shares (3 million shares) to secure repayment.

• · The share loan agreement was executed on June 29, 2026, with Southern SelliBen Trust as lender and Mzilikazi Godfrey Khumalo as borrower.
• · Khumalo borrowed up to 14 million ordinary shares and must redeliver up to 14 million Equivalent Shares (or pay cash value) by the Longstop Date or upon written notice from the lender.
• · The loan carries a $50,000 upfront fee plus 13% p.a. interest, payable monthly, calculated on the value of the loaned shares at closing price on the loan date.
• · Khumalo granted the lender a security interest in his earnout shares (up to 3 million shares) as collateral for the loan.
• · Khumalo's beneficial ownership remained at 7.1% of the outstanding shares, but the loan adds significant off-balance-sheet share exposure (up to 14M shares) and potential dilution if the earnout shares are not received.
• · The reporting person is a South African citizen, resident in Geneva, Switzerland, and his principal occupation is investor/entrepreneur.
• · No other person has the right to receive dividends or proceeds from the sale of the shares held by Khumalo.

24-08-2026

Integrity Wealth Advisors, Inc. filed a Schedule 13G/A disclosing beneficial ownership of 6,286,132 shares of Genasys Inc. common stock, representing 13.80% of the outstanding shares as of June 30, 2026. The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · Integrity Wealth Advisors, Inc. is an investment adviser (IA) based in Ventura, California.
• · The filing certifies that the securities were not acquired to change or influence control of Genasys Inc.

24-08-2026

Kenneth R. Lehman filed a Schedule 13G/A with the SEC on August 24, 2026, disclosing beneficial ownership of 993,343 shares of Burke & Herbert Financial Services Corp. common stock, representing a 4.9% stake. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · Kenneth R. Lehman has sole voting and dispositive power over all 993,343 shares.
• · The filing was made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
• · The beneficial ownership is below the 5% threshold, at 4.9%.

24-08-2026

Feis Equities LLC and its managing member Lawrence M. Feis filed an amended Schedule 13G with the SEC on August 24, 2026, disclosing beneficial ownership of 611,464 Class A ordinary shares of BOA Acquisition Corp. II, representing 4.25% of the 14,375,000 shares outstanding as of August 5, 2026. The filing indicates passive investment intent, with no purpose or effect of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c), indicating passive investor status.
• · Feis Equities LLC is an Illinois limited liability company; Lawrence M. Feis is an individual and managing member.
• · The beneficial ownership is reported as sole voting and dispositive power over all 611,464 shares by both Feis Equities LLC and Lawrence M. Feis.
• · The issuer, BOA Acquisition Corp. II, is a blank check company (SIC 6770) incorporated in the Cayman Islands (E9).

24-08-2026

Kite Lake Capital Management (UK) LLP and related entities filed an amended Schedule 13G with the SEC on August 24, 2026, disclosing beneficial ownership of 11,206,225 shares of Optimum Communications, Inc. (formerly Altice USA) Class A common stock, representing 6.8% of the outstanding class. The filing updates a prior 13G from July 9, 2026, which reported a 3.3% stake, reflecting both additional acquisitions and a revised share count following the company's tender offer of 120,000,000 shares on July 6, 2026. The increase in ownership percentage from 3.3% to 6.8% is driven by both new purchases and a reduced denominator due to the tender offer.

• · The filing is an amendment to a Schedule 13G originally filed on July 9, 2026.
• · The ownership percentage calculation is based on 163,699,534 Class A shares outstanding, derived from 272,565,547 total Class A and B shares minus 108,866,013 Class B shares.
• · The tender offer of 120,000,000 shares on July 6, 2026 significantly reduced the Class A share count from 283,694,377 (June 30, 2026) to approximately 163,699,534 (July 31, 2026).
• · KL Special Opportunities Master Fund Ltd directly owns 10,085,615 shares (6.2%), while the remaining Kite Lake entities each report 11,206,225 shares (6.8%).
• · All reported securities are directly owned by advisory clients of Kite Lake Capital Management (UK) LLP; no single advisory client other than KL Special Opportunities Master Fund Ltd is deemed to beneficially own more than 5%.
• · Each reporting person disclaims beneficial ownership except to the extent of pecuniary interest.

24-08-2026

Benjamin Weinstein reported beneficial ownership of 1,105,720 shares of Precision Biosciences Inc., representing 4.01% of the 27,601,554 shares outstanding as of August 3, 2026. The position includes 203,500 shares issuable upon warrant exercise; Weinstein stated that the securities were not acquired or held to change or influence control of the company.

• · The filing was submitted as Schedule 13G/A on August 24, 2026 under Rule 13d-1(c).
• · Precision Biosciences Inc. is headquartered at 302 East Pettigrew Street, Suite A-100, Durham, North Carolina 27701.
• · The reported securities were not held in connection with a transaction intended to change or influence control of the issuer.

24-08-2026

Five Narrow Lane LP filed a Schedule 13G disclosing beneficial ownership of 96,137 shares of Expion Energy Inc. (f/k/a Expion360 Inc.), representing 9.99% of the 962,335 shares outstanding as of August 6, 2026. The filing is a passive investment under Rule 13d-1(c), and the ownership is contractually capped at 9.99%, meaning the fund would hold more shares if not for this restriction. No period-over-period comparisons are available as this is an initial filing.

• · The filing is made under Rule 13d-1(c), indicating a passive investment intent.
• · The ownership is contractually capped at 9.99%; full conversion/exercise of securities would exceed this limit.
• · The company changed its name from Expion360 Inc. to Expion Energy Inc. on November 19, 2021.

24-08-2026

Bradley Radoff, a director of Harte Hanks Inc. (HHS), disclosed beneficial ownership of 423,447 shares (5.7% of outstanding) in an amended Schedule 13D/A filed August 24, 2026. The filing details a merger agreement entered into on August 14, 2026, under which Star Equity Holdings will acquire HHS for $5.00 per share in cash and/or 0.50 shares of Star Preferred Stock per share. Radoff has entered into a voting and support agreement to vote his shares in favor of the merger, which is subject to stockholder approval and other conditions.

• · Radoff's 423,447 shares represent 5.7% of HHS outstanding shares based on 7,454,240 shares outstanding as of July 31, 2026.
• · Radoff purchased 368,900 shares with personal funds for an aggregate purchase price of approximately $1,958,836.
• · Radoff was awarded 82,408 RSUs under the 2020 Equity Incentive Plan; 54,547 have vested and 27,861 will vest on December 9, 2026.
• · The merger consideration is $5.00 per share in cash and/or 0.50 shares of Star Preferred Stock per share.
• · The Support Agreement terminates upon the earlier of the effective time of the merger, valid termination of the Merger Agreement, an adverse recommendation change by HHS board, certain amendments without Radoff's consent, or mutual written agreement.
• · No transactions in HHS securities by Radoff during the past 60 days.